100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.2 TrustPilot
logo-home
Summary

Asthma - Summary Notes

Rating
-
Sold
-
Pages
3
Uploaded on
01-06-2023
Written in
2022/2023

A comprehensive, yet concise summary of the Asthma topic in Medicine/ Surgery, presented in a colourful and digestible format. Includes all relevant information on the topic summarised, collated from multiple resources including lectures, textbooks, and guidelines. All my notes/ summaries use a consistent colour scheme, style, and structure to help you remember their contents.

Show more Read less








Whoops! We can’t load your doc right now. Try again or contact support.

Document information

Uploaded on
June 1, 2023
Number of pages
3
Written in
2022/2023
Type
Summary

Content preview

Respiratory
ASTHMC
Asthma
Asthma-Chronic, reversible airway obstruction, Contraindications:

causing repeatepisodes of Dyspnoea, wheeze, and cough.
·
obstruction is caused from -



B-blockers
inflammation, bronchial muscle spasm, and mucus production. NSAIDs
-




ACE Inhibitors
-




Diagnosis:

Diagnosed through history and spirometry/peakflow showing variable expiration.
·




spirometry shows varying FEV1 12%/200m1 when conducting reversibility test.
Peak flow varies 10%.


Spirometry Reversibility Test used to differentiate Asthma/COPD obstructive disease
-




baseline FEV1 is compared to FEV1after salbutamol, in order to assess reversibility.
·




Treatment Ladder:
Triggers/Risk Factors:

Allergy

-




Go up/down Asthma treatment ladder as Aspirin
necessary:
-




Child onset
Exercise,
-




all asthmatics should have BLUE INHALER Cold
·
air
-




Short-Acting B2-Agonist (SABA) e.g. salbutamol, FH
-




for quick relief. obesity
Adultonset
-




BROWN INHALER -




smoking




I
. Inhaled Corticosteroid (ICS):e.g. Becomethasone.


ICS is used for prevention, notrelief.
Loccupational PINRINHALER:Fostain
in





wash mouth after ICS to prevent candida. Beclemethasone + Formeterol
GREEN INHALER ICS + LABA
2. add
Long-Acting B2-Agonist (LABA):e.g. Salmeterol,
Formeterol.
is ineffective,
ifLABA from
remove it
plan.

3. Increase ICS dose and / or
add Leukotrine Receptor Agonist (LTRA) e.g. oral montelukast.
TREATMENT AIMS


4.add oral corticos teroid Prednisolone and / or
ASTHMA
specialisttreatmentlike Omalizumab monoclonal antibodies.
TREATMENT LADDER
£5.49
Get access to the full document:

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

Get to know the seller
Seller avatar
barhaman

Also available in package deal

Thumbnail
Package deal
Clinical Respiratory - Summary Notes Bundle
-
10 2023
£ 48.90 More info

Get to know the seller

Seller avatar
barhaman The University of Birmingham
View profile
Follow You need to be logged in order to follow users or courses
Sold
1
Member since
2 year
Number of followers
2
Documents
34
Last sold
1 year ago

0.0

0 reviews

5
0
4
0
3
0
2
0
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their exams and reviewed by others who've used these revision notes.

Didn't get what you expected? Choose another document

No problem! You can straightaway pick a different document that better suits what you're after.

Pay as you like, start learning straight away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and smashed it. It really can be that simple.”

Alisha Student

Frequently asked questions